September 01, 2015 – The American Food and Drug Administration recently approved Evolocumab (Repatha) injection for some patients who are unable to get their low-density lipoprotein (LDL) cholesterol under control with current treatment options. Evolocumab (Repatha), the second drug approved in a …

Evolocumab (Repatha) to treat certain patients with high cholesterol Read more »